Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Mycoses 3Leukemia, Myeloid, Acute 3Myelodysplastic Syndromes 2Leukemia 2Hematologic Neoplasms 2Neutropenia 1Neoplasms 1Invasive Fungal Infections 1Bronchiolitis Obliterans Syndrome 1Bone Marrow Neoplasms 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

fludarabine phosphate 3Antilymphocyte Serum 3Whole-Body Irradiation 2Cyclophosphamide 2treosulfan 1thymoglobulin 1posaconazole 1fludarabine 1X-Rays 1Thiotepa 1Tacrolimus 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Busulfan 1Bone Marrow Transplantation 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Bone Marrow Failure Disorders × posaconazole × Clear all
NCT02358499 2020-12-22

Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children

Children's Mercy Hospital Kansas City

Phase 1 Completed
31 enrolled
Other hematologic neoplasm

Bone Marrow Failure Disorders, Leukemia, Mycoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡